ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1419	National Cancer Institute	Html	en	Lung Cancer Screening (PDQ®)–Health Professional Version	Expert-reviewed information summary about tests used to detect or screen for lung cancer.	lung cancer screening 0.756773 initial screening test 0.3898 LDCT lung cancer 0.431859 sputum cytology 0.442562 U.K. Lung Cancer 0.42482 negative screening test 0.411746 lung cancer 0.9987 lung cancer mortality. 0.430481 current smokers 0.386204 intense screening regimen 0.386147 Early Lung Cancer 0.463536 chest imaging 0.420806 positive screening result 0.397336 lung abnormalities 0.397732 excess lung cancer 0.416122 Lung Screening Trial 0.503515 group 0.383474 intervention arm 0.382743 lung cancer problem 0.42431 positive screening test 0.414453 screening phase 0.386735 lung cancers 0.45033 major lung abnormality 0.402566 LDCT screening 0.417092 lung cancer cases 0.428353	randomized Danish Lung 0.39566 positive screening tests 0.398319 chest radiographic screening 0.412733 cancer screening program 0.414425 lung component 0.385589 Danish Lung Cancer 0.447818 Screening pilot trial 0.393797 Lung Cancer Action 0.443317 participants 0.389736 National Lung Screening 0.500437 Lung Cancer Detection 0.423833 CT screening program 0.391863 Randomized Lung Cancer 0.430455 small lung cancers 0.401362 screening exams 0.383361 lung cancer. 0.390552 lung cancer deaths 0.457228 PLCO Cancer Screening 0.408534 lung cancer death 0.470333 Mayo Lung Project 0.426524 screening test 0.418941 lung cancer mortality 0.632713 lung cancer incidence 0.423847 Cancer Screening Trial 0.513616	CLICK HERE
1485	National Cancer Institute	Html	en	Intraocular (Uveal) Melanoma Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of intraocular (eye) melanoma.	uveal melanoma 0.68476 Medium Tumor Trial 0.539127 charged-particle ebrt 0.585479 local tumor regrowth 0.547533 125I brachytherapy 0.543775 uveal melanomas 0.962507 Option Overview section 0.565872 local tumor recurrence. 0.544248 posterior uveal melanomas 0.679007 plaque radiation therapy 0.595583 tumor regression rates 0.537853 uveal tract melanomas 0.717461 late local radiation 0.532096 ocular melanoma 0.519667 histopathologically confirmed melanoma 0.546989 large choroidal tumors 0.551303 small melanomas 0.610711 brachytherapy 0.555626 all-cause mortality rates 0.515468 U.S. incidence rates 0.52364 local control rate 0.579941 melanoma metastasis-specific survival 0.54531 prominent tumor vascularity 0.525035 posterior melanomas 0.676788	large uveal melanomas 0.659428 patients 0.552792 visual acuity 0.646161 optic disc 0.638287 ciliary body 0.761795 small choroidal melanoma 0.601669 ciliary body melanoma 0.589002 medium-sized choroidal tumors 0.551291 relatively good outcomes 0.576295 tumors 0.574964 Treatment Option Overview 0.566892 tumor growth warrants 0.54471 posterior uveal tract 0.542964 tumor 0.654818 unequivocal tumor growth 0.619495 anterior ciliary body 0.517737 radiation therapy 0.658453 local tumor control 0.613746 ocular melanomas 0.634519 typical choroidal melanoma 0.592701 statistically significant differences 0.571591 small choroidal melanomas 0.778268 iris melanomas 0.919191	CLICK HERE
1542	National Cancer Institute	Html	en	Uterine Sarcoma Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of uterine sarcomas.	cancer treatment 0.326283 cancer spreads 0.27392 body 0.30595 PDQ cancer information 0.340432 clinical trial search 0.337812 uterus 0.36876 metastatic uterine sarcoma 0.28805 clinical trials 0.632813 cancer information summary 0.313263 clinical trial 0.463679 Transvaginal ultrasound exam 0.270971 patients 0.291529 Recurrent uterine sarcoma 0.312941 total abdominal hysterectomy 0.33979 treatment clinical trial 0.271689 NCI PDQ cancer 0.280198 Treatment Option Overview 0.316082 radiation therapy 0.397408 Treatment Editorial Board 0.278942 General information 0.276617 general cancer information 0.27165 treatment 0.476479 uterine sarcoma cells 0.294562 NCI-supported cancer 0.289424 cancer cells 0.449324	Cancer Information Service 0.272134 Uterine Sarcoma Treatment 0.298886 Option Overview section 0.306678 Uterine Cancer Home 0.286123 treatment clinical trials 0.296817 National Cancer Institute 0.35406 new treatment 0.296864 uterine sarcoma 0.941913 Uterine Sarcoma section 0.285791 diagnose uterine sarcoma 0.300059 PDQ summary 0.281429 uterine sarcoma spreads 0.28676 cancer clinical trials 0.348942 stage 0.302932 Endometrial Cancer Treatment 0.295433 high-energy sound waves 0.275392 fallopian tubes 0.310914 Tissue Sarcoma Treatment 0.291575 treatment options 0.275101 cancer information summaries 0.270428 comprehensive cancer information 0.27068 cancer 0.782046 information 0.353338 standard treatment 0.299992	CLICK HERE
1551	National Cancer Institute	Html	null	Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of childhood acute myeloid leukemia, myelodysplastic syndromes, and other myeloproliferative disorders.			CLICK HERE
1567	National Cancer Institute	Html	en	Metastatic Squamous Neck Cancer with Occult Primary Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of metastatic squamous neck cancer with occult primary.	cancer treatment 0.331255 neck muscles 0.258524 cancer spreads 0.287607 metastatic cancer 0.293108 malignant tumor cells 0.281382 body 0.321816 PDQ cancer information 0.347021 squamous cells 0.294186 clinical trial search 0.272504 external radiation treatment 0.262886 clinical trials 0.659393 cancer information summary 0.31748 clinical trial 0.463543 squamous cell cancer 0.363064 breast cancer prevention 0.264993 radical neck dissection 0.322726 patients 0.300058 earlier clinical trials 0.261657 treatment clinical trial 0.277097 PDQ Adult Treatment 0.268031 different types 0.294996 NCI PDQ cancer 0.286254 tests 0.272201 radiation therapy 0.490196 Treatment Editorial Board 0.283384	lung cancer cells 0.288937 currently used treatment 0.262475 metastatic squamous neck 0.988686 treatment 0.481959 Occult Primary Treatment 0.275159 new cancer treatments 0.27464 cancer cells 0.387801 Cancer Information Service 0.273937 PDQ Metastatic Squamous 0.312989 Hyperfractionated radiation therapy 0.272771 treatment clinical trials 0.300592 squamous neck cancer 0.954253 National Cancer Institute 0.34026 occult primary 0.527765 new treatment 0.321855 new treatments 0.258619 Cancer Care page 0.264657 primary tumor 0.396235 cancer research process 0.267043 cancer clinical trials 0.302055 treatment options 0.305059 cancer information summaries 0.272694 comprehensive cancer information 0.272807 occult primary tumor 0.271623	CLICK HERE
1656	National Cancer Institute	Html	null	Last Days of Life (PDQ®)–Health Professional Version	Expert-reviewed information summary about care during the last days to last hours of life, including common symptoms, ethical dilemmas that may arise, and the role of the oncologist in caring for patients and their families during this time.			CLICK HERE
2032	National Cancer Institute	Html	es	Exámenes de detección del cáncer de próstata (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca de las pruebas utilizadas para detectar el cáncer de próstata.	or watchful waiting 0.527761 Prostate Cancer Group-4 0.536467 Koyama T 0.514342 estudio erspc 0.525762 Sin embargo 0.633101 Resnick MJ 0.514745 países cuáles factores 0.523397 detección versus 0.572904 Holmberg L 0.514356 ensayo plco 0.516954 Swedish Cancer Registry 0.524495 Ahmed HU 0.514521 jurisdicciones europeas colaboradoras 0.519184 Preventive Services Task 0.58607 Ovarian Cancer Screening 0.580102 consiguiente tratamiento 0.524752 Croswell JM 0.515275 estudio prostate testing 0.532458 Estados Unidos 0.630717 centro göteborg 0.570246 siguientes tasas 0.517703 Prostate Cancer Prevention 0.525333 PSA rutinarias 0.626469 FJ Jr 0.514192 evolución natural benigna 0.523168	centro sueco göteborg 0.523946 trascendencia clínica 0.542862 Lancet Oncol 0.516366 Eur Urol 0.51628 End Results 0.514418 Loeb S 0.514034 Scandinavian Prostate Cancer 0.583772 seguimiento diagnóstico 0.518794 Gen Intern Med 0.526679 lesiones prostáticas benignas 0.525347 radical prostatectomy 0.520653 Países Bajos 0.556513 Fan KH 0.51463 edad promedio 0.515679 Chou R 0.514768 PDQ Tratamiento 0.51809 European Randomized Study 0.573324 Intern Med 0.549412 Steineck G 0.514536 Services Task Force 0.584434 prostate cancer 0.738954 datos probatorios 0.915311 Prostate Intervention Versus 0.524636 Cancer Screening Trial 0.580497	CLICK HERE
3675	National Cancer Institute	Html	en	Data Submission Under the Genomic Data Sharing (GDS) Policy	Information for intramural, extramural, and non-NIH funded investigators looking to submit study data under the Genomic Data Sharing (GDS) Policy.	data instruments 0.389578 Different submission requirements 0.358856 Different data types 0.458311 data 0.914172 N/A Arrays 0.352863 Institutional Certification 0.390929 data use limitations 0.365334 phenotype data 0.455331 DNA sequence data 0.507348 clinical information 0.351464 N/A .BAM Arrays 0.717463 common data elements 0.45555 NCI intramural research 0.372571 RNAseq data 0.381683 submission process 0.341088 SNP array data 0.440533 Data reuse 0.406127 genomic data 0.788599 genomic program administrator 0.366093 controlled-access genomic data 0.507551 Raw data 0.388186 bisulfite sequencing data 0.488737 data sharing plan 0.431561 scientific review 0.378953	basis N/A .TXT 0.57172 GWAS data 0.384745 data standards 0.487591 published table 0.34424 human genomic data 0.471234 additional research questions 0.363874 data processing 0.449487 GDS policy-covered research 0.360223 human sample data 0.554048 GDS website 0.358009 DNA methylation data 0.435253 NIH data repositories 0.466908 minimizes potential errors 0.345345 data generation 0.367981 Developing Data Sharing 0.429887 exposure data 0.441991 well-documented data standards 0.480779 genomic data—such 0.394593 data submission 0.621641 data release 0.391289 NIH National Center 0.357378 genomic data submissions 0.597871 N/A .BAM NGS 0.52976	CLICK HERE
16648	National Cancer Institute	Html	en	Track 3: Oncology Product Research and Review for Postdoctoral Research Fellows	NCI and FDA collaborate to train physicians in aspects of drug, biologic, or device development and standards for assessing medical product safety. Learn more about this cancer training program.	FDA medical product 0.724157 pharmacology/toxicology branch 0.567867 regulatory research 0.567201 manufacturing processes 0.657075 reviewer training 0.533228 FDA scientific review 0.647979 regulatory requirements 0.555708 regulatory meetings 0.534128 Medical Center Dr 0.604857 fellows 0.948854 product-related research 0.563223 molecular targeted therapy 0.645977 translational research 0.550405 manufacturing control 0.548537 research goals 0.538726 post-marketing surveillance 0.528754 quality control 0.651731 Regulatory Review Fellowships 0.633391 branch chief 0.620999 research activities 0.549015 pharmacology/toxicology reviews 0.559001 particular product division 0.677124 FDA Centers 0.6466 product standards 0.562937 quality assurance 0.652186	Review list 0.528745 training program 0.540221 various training activities 0.644892 relevant federal statutes 0.651561 formal training 0.557556 earliest start date 0.598748 critical ethical issues 0.628449 medical product development 0.721681 product research 0.592749 clinical trial design 0.65091 postdoctoral training 0.552346 product development 0.822368 regulatory presentations 0.533763 human research subjects 0.664846 guidance document development 0.635078 regulatory files 0.555901 principal investigators 0.629995 approval process 0.53653 NCI-FDA Research 0.537698 program time frame 0.62474 division director 0.626349 supplemental training 0.540819 regulatory experience 0.537743 cancer biology 0.538989	CLICK HERE
16861	National Cancer Institute	Html	es	Terapia Gerson (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre el uso de la terapia Gerson como tratamiento para personas con cáncer. Nota: La información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.	múltiples detalles 0.301338 Centro Nacional 0.302469 New Hampshire Avenue 0.301732 Drug Administration 0.301078 NCI Best Case 0.303308 Max B 0.30156 datos bibliográficos pubmed 0.30187 cuerpo suficientes vitaminas 0.303678 Vitaminas A 0.301419 siguientes preguntas 0.30102 National Cancer Institute 0.302137 siguientes riesgos 0.301292 vitamina b12 0.301563 alto contenido 0.301449 Instituto Nacional 0.314894 Gerson Research Organization 0.308778 Salud Complementaria 0.303978 Visuals Online 0.301269	complementarias revisa 0.301833 PDQ Terapia Gerson 0.311186 Physician Data Query 0.307427 comidas vegetarianas 0.301548 coenzima q10 0.304748 Estados Unidos 0.316664 enzimas pancreáticas 0.305305 libre uso 0.301348 página manejo 0.301179 ¿El tratamiento 0.302348 suficiente potasio 0.301916 ¿Los beneficios 0.301092 juntos cam 0.301043 numerosos detalles 0.301552 Series Program 0.301073 terapia gerson 0.988974 medicina complementaria 0.349955	CLICK HERE